EP1332154A4 - Nouvelles compositions therapeutiques pour traiter une infection par lawsonia spp - Google Patents

Nouvelles compositions therapeutiques pour traiter une infection par lawsonia spp

Info

Publication number
EP1332154A4
EP1332154A4 EP01983297A EP01983297A EP1332154A4 EP 1332154 A4 EP1332154 A4 EP 1332154A4 EP 01983297 A EP01983297 A EP 01983297A EP 01983297 A EP01983297 A EP 01983297A EP 1332154 A4 EP1332154 A4 EP 1332154A4
Authority
EP
European Patent Office
Prior art keywords
therapeutic compositions
novel therapeutic
treating infection
lawsonia spp
lawsonia
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP01983297A
Other languages
German (de)
English (en)
Other versions
EP1332154A1 (fr
Inventor
Everett Lee Rosey
Kendall Wayne King
Robert Trygve Good
Richard Anthony Strugnell
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Agriculture Victoria Services Pty Ltd
Australian Pork Ltd
Pfizer Products Inc
Original Assignee
Agriculture Victoria Services Pty Ltd
Australian Pork Ltd
Pfizer Products Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AUPR1381A external-priority patent/AUPR138100A0/en
Application filed by Agriculture Victoria Services Pty Ltd, Australian Pork Ltd, Pfizer Products Inc filed Critical Agriculture Victoria Services Pty Ltd
Publication of EP1332154A1 publication Critical patent/EP1332154A1/fr
Publication of EP1332154A4 publication Critical patent/EP1332154A4/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/205—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Campylobacter (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53—DNA (RNA) vaccination
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
EP01983297A 2000-11-10 2001-11-09 Nouvelles compositions therapeutiques pour traiter une infection par lawsonia spp Withdrawn EP1332154A4 (fr)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
AUPR1381A AUPR138100A0 (en) 2000-11-10 2000-11-10 Novel therapeutic compositions for treating infection by lawsonia spp
AUPR138100 2000-11-10
US24959600P 2000-11-17 2000-11-17
US249596P 2000-11-17
PCT/AU2001/001462 WO2002038594A1 (fr) 2000-11-10 2001-11-09 Nouvelles compositions therapeutiques pour traiter une infection par lawsonia spp

Publications (2)

Publication Number Publication Date
EP1332154A1 EP1332154A1 (fr) 2003-08-06
EP1332154A4 true EP1332154A4 (fr) 2005-05-11

Family

ID=25646507

Family Applications (1)

Application Number Title Priority Date Filing Date
EP01983297A Withdrawn EP1332154A4 (fr) 2000-11-10 2001-11-09 Nouvelles compositions therapeutiques pour traiter une infection par lawsonia spp

Country Status (7)

Country Link
EP (1) EP1332154A4 (fr)
JP (1) JP2004512851A (fr)
BR (1) BR0114835A (fr)
CA (1) CA2399276A1 (fr)
MX (1) MXPA03003077A (fr)
NZ (1) NZ520600A (fr)
WO (1) WO2002038594A1 (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003295341A1 (en) * 2002-10-04 2004-05-04 Regents Of The University Of Minnesota Nucleic acid and polypeptide sequences from lawsonia intracellularis and methods of using
US8834891B2 (en) 2005-03-14 2014-09-16 Boehringer Ingelheim Vetmedica, Inc. Immunogenic compositions comprising Lawsonia intracellularis
US8398994B2 (en) 2005-07-15 2013-03-19 Boehringer Ingelheim Vetmedica, Inc. Lawsonia vaccine and methods of use thereof
US20100129397A1 (en) 2006-12-11 2010-05-27 Boehringer Ingelheim Vetmedica, Inc. Effective method of treatment of porcine circovirus and lawsonia intracellularis infections
FR2980213B1 (fr) * 2011-09-16 2013-09-06 Biomerieux Sa Procede de caracterisation de bacteries, par detection de proteines non-structurales de bacteriophages
US9359643B2 (en) * 2013-03-08 2016-06-07 Progenika Biopharma S.A. Discrimination of blood type variants
CL2017002196A1 (es) 2017-08-30 2017-11-17 Univ De Concepción Vacuna recombinante contra enteropatía proliferativa en animales.

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997020050A1 (fr) * 1995-11-30 1997-06-05 Daratech Pty. Ltd. Compositions therapeutiques et diagnostiques
WO1999058682A2 (fr) * 1998-05-12 1999-11-18 Smithkline Beecham Biologicals S.A. Composes derives de moraxella catarrhalis
EP1001025A2 (fr) * 1998-10-22 2000-05-17 Pfizer Products Inc. Protéines principales de la membrane externe de actinobacillus pleuropneumoniae
WO2000047737A1 (fr) * 1999-02-09 2000-08-17 Smithkline Beecham Biologicals S.A. Séquences de membrane externe de hemophilus influenza rd utilisées en tant que vaccin

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5885823A (en) * 1995-06-05 1999-03-23 Nobl Laboratories, Inc. Lawsonia intracellularis cultivation, anti-Lawsonia intracellularis vaccines and diagnostic agents

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997020050A1 (fr) * 1995-11-30 1997-06-05 Daratech Pty. Ltd. Compositions therapeutiques et diagnostiques
WO1999058682A2 (fr) * 1998-05-12 1999-11-18 Smithkline Beecham Biologicals S.A. Composes derives de moraxella catarrhalis
EP1001025A2 (fr) * 1998-10-22 2000-05-17 Pfizer Products Inc. Protéines principales de la membrane externe de actinobacillus pleuropneumoniae
WO2000047737A1 (fr) * 1999-02-09 2000-08-17 Smithkline Beecham Biologicals S.A. Séquences de membrane externe de hemophilus influenza rd utilisées en tant que vaccin

Non-Patent Citations (22)

* Cited by examiner, † Cited by third party
Title
CARPENTER PHILLIP B ET AL: "Bacillus subtilis flagellar proteins FliP, FliQ, FliR and FlhB are related to Shigella flexneri virulence factors", GENE (AMSTERDAM), vol. 137, no. 2, 1993, pages 243 - 245, XP002306955, ISSN: 0378-1119 *
DALE C JANE H ET AL: "Identification and sequencing of the groE operon and flanking genes of Lawsonia intracellularis: Use in phylogeny", MICROBIOLOGY, SOCIETY FOR GENERAL MICROBIOLOGY, READING, GB, vol. 144, no. 8, August 1998 (1998-08-01), pages 2073 - 2084, XP002156652, ISSN: 1350-0872 *
DATABASE EMBL [online] 18 October 1999 (1999-10-18), "Salmonella typhimurium DNA for MotB protein, partial, MotA protein, FlhC protein, FlhD protein, UspA analogue.", XP002318066, retrieved from EBI accession no. EM_PRO:D43640 Database accession no. D43640 *
DATABASE EMBL [online] 30 March 2001 (2001-03-30), "602541693F1 NIH_MGC_59 Homo sapiens cDNA clone IMAGE:4672631 5', mRNA sequence.", XP002318063, retrieved from EBI accession no. EM_PRO:BG495022 Database accession no. BG495022 *
DATABASE EMBL [online] 6 September 1996 (1996-09-06), "Vibrio parahaemolyticus lateral flagellin LafA (lafA), lateral flagellar FliD (fliD), lateral flagellar FliS (fliS), lateral flagellar FliT-like protein (fliT), lateral flagellar FliK-like protein (fliK), lateral flagellar FliL (fliL), lateral flagellar FliA (fliA), lateral flagellar MotA (motA), an", XP002318064, retrieved from EBI accession no. EM_PRO:VPU52957 Database accession no. VPU52957 *
DATABASE EMBL 1 June 2001 (2001-06-01), FERRETTI ET AL.: "Hypothetical protein SPy1315.", XP002318062, Database accession no. Q99ZA4 *
DATABASE EMBL 1 June 2001 (2001-06-01), NIERMAN ET AL.: "Hypothetical protein CC1604.", XP002318072, Database accession no. Q9A7W5 *
DATABASE EMBL 1 March 2001 (2001-03-01), STOVER ET AL.: "Chemotaxis protein MotA", XP002318065, Database accession no. Q9HUL1 *
DATABASE EMBL 1 November 1999 (1999-11-01), LEE ET AL.: "Hypothetical protein", XP002318071, Database accession no. Q9X3V6 *
DATABASE EMBL 1 November 1999 (1999-11-01), LEE ET AL: "Hypothetical protein", XP002318069, Database accession no. Q9X3V8 *
DATABASE EMBL 1 November 1999 (1999-11-01), STAMM ET AL.: "Flagellar motor protein MotB (flagellar motor protein B)", XP002318067, Database accession no. Q9X5A1 *
DATABASE EMBL 1 October 2000 (2000-10-01), HEIDELBERG ET AL.: "Amino acid ABC transporter, periplasmic amino acid-binding protein.", XP002318061, Database accession no. Q9KKKR3 *
DATABASE EMBL 1 October 2000 (2000-10-01), TAKAMI ET AL.: "Flagellar biosynthetic protein fliR", XP002318060, Database accession no. Q9KA50 *
DATABASE EMBL 1 October 2001 (2001-10-01), KANEKO ET AL.: "Mll1662 protein.", XP002318070, Database accession no. Q98K30 *
DATABASE UniProt [online] 15 July 1998 (1998-07-15), "Hypothetical UPF0053 protein sll1254.", XP002318068, retrieved from EBI accession no. UNIPROT:Y1254_SYNY3 Database accession no. Y1254_SYNY3 *
DEAN G E ET AL: "GENE SEQUENCE AND PREDICTED AMINO-ACID SEQUENCE OF THE MOT-A PROTEIN A MEMBRANE-ASSOCIATED PROTEIN REQUIRED FOR FLAGELLAR ROTATION IN ESCHERICHIA-COLI", JOURNAL OF BACTERIOLOGY, vol. 159, no. 3, 1984, pages 991 - 999, XP009044086, ISSN: 0021-9193 *
PAWLOWSKI K ET AL: "CHARACTERIZATION OF A NOVEL AZORHIZOBIUM-CAULINODANS ORS571 TWO-COMPONENT REGULATORY SYSTEM NTRY-NTRX INVOLVED IN NITROGEN FIXATION AND METABOLISM", MOLECULAR AND GENERAL GENETICS, vol. 231, no. 1, 1991, pages 124 - 138, XP001205245, ISSN: 0026-8925 *
PLATZER J ET AL: "Three genes of a motility operon and their role in flagellar rotary speed variation in Rhizobium meliloti.", JOURNAL OF BACTERIOLOGY. OCT 1997, vol. 179, no. 20, October 1997 (1997-10-01), pages 6391 - 6399, XP002318059, ISSN: 0021-9193 *
See also references of WO0238594A1 *
STAMM LOLA V ET AL: "Molecular characterization of a flagellar (fla) operon in the oral spirochete Treponema denticola ATCC 35405", FEMS MICROBIOLOGY LETTERS, vol. 179, no. 1, 1 October 1999 (1999-10-01), pages 31 - 36, XP002318058, ISSN: 0378-1097 *
STEGLITZ-MÖRSDORF U ET AL: "Cloning, heterologous expression, and sequencing of the Proteus vulgaris glnAntrBC operon and implications of nitrogen control on heterologous urease expression.", FEMS MICROBIOLOGY LETTERS. 15 JAN 1993, vol. 106, no. 2, 15 January 1993 (1993-01-15), pages 157 - 164, XP001205246, ISSN: 0378-1097 *
YANAGIHARA SHIGEHIRO ET AL: "Structure and transcriptional control of the flagellar master operon of Salmonella typhimurium", GENES AND GENETIC SYSTEMS, vol. 74, no. 3, June 1999 (1999-06-01), pages 105 - 111, XP002318057, ISSN: 1341-7568 *

Also Published As

Publication number Publication date
WO2002038594A1 (fr) 2002-05-16
JP2004512851A (ja) 2004-04-30
CA2399276A1 (fr) 2002-05-16
MXPA03003077A (es) 2003-09-25
BR0114835A (pt) 2003-07-01
EP1332154A1 (fr) 2003-08-06
NZ520600A (en) 2004-08-27
WO2002038594A9 (fr) 2002-11-07

Similar Documents

Publication Publication Date Title
MXPA03003168A (es) Composicion antibiotica topica para el tratamiento de infeccion de los ojos.
IL188834A0 (en) Novel vaccine composition
AP2002002700A0 (en) Vaccine composition
GB0020089D0 (en) Vaccine Composition
GB0128851D0 (en) Fabric treatment compositions
HUP0105379A3 (en) Lawsonia intracellularis vaccine
EG25829A (en) Novel treatment
HUP0400609A3 (en) Wet-skin treatment compositions
HUP0303942A3 (en) Novel vaccine composition
GB0015690D0 (en) Fabric treatment composition
GB0012061D0 (en) Hair treatment compositions
EP1332154A4 (fr) Nouvelles compositions therapeutiques pour traiter une infection par lawsonia spp
AU5735701A (en) Seed treatment composition
AUPR138100A0 (en) Novel therapeutic compositions for treating infection by lawsonia spp
GB0009607D0 (en) Medical compositions
HK1046848A1 (en) Specific therapeutic composition for treating aids
GB0118936D0 (en) Improvements relating to colour-safe fabric treatment compositions
GB0114540D0 (en) Laundry treatment composition
GB0007659D0 (en) Laundry treatment compositions
GB0030956D0 (en) Stain treatment composition
IL159333A0 (en) Plant treatment composition
GB0000556D0 (en) Malodour treatment compositions
GB0012064D0 (en) Hair treatment compositions
GB0123063D0 (en) Compositions for therapy
GB0006770D0 (en) Vaccine composition

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20021210

AK Designated contracting states

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR

AX Request for extension of the european patent

Extension state: AL LT LV MK RO SI

A4 Supplementary search report drawn up and despatched

Effective date: 20050324

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20060731

REG Reference to a national code

Ref country code: HK

Ref legal event code: WD

Ref document number: 1057902

Country of ref document: HK